SHERIDAN, WYOMING – May 27, 2025 – Roche has announced an encouraging update on its supplemental Biologics License Application (sBLA) for Columvi® (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx), following discussion by the FDA’s Oncologic Drugs Advisory Committee (ODAC). The combination therapy demonstrated a significant 41% reduction in the risk of death in patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL) who are not candidates for autologous stem cell transplant.

Landmark survival data in STARGLO trial supports regulatory momentum

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced FDA approval of its VENTANA® MET (SP44) RxDx Assay, marking a major milestone in companion diagnostics for non-small cell lung cancer (NSCLC). This approval paves the way for a more precise identification of patients eligible for AbbVie’s Emrelis™ (telisotuzumab vedotin-tllv), a targeted therapy for non-squamous NSCLC with MET protein overexpression.

Enhancing Treatment Precision in Lung Cancer Care

The VENTANA MET (SP44) RxDx Assay is the first FDA-approved companion diagnostic for detecting MET protein expression in NSQ-NSCLC patients. By identifying those with elevated levels of MET—a key predictive biomarker—the assay supports clinicians in selecting patients who are most likely to benefit from c-Met-targeted therapy.

SHERIDAN, WYOMING – May 27, 2025 – Roche has announced compelling final results from the decade-long APHINITY Phase III clinical trial, demonstrating a significant 17% reduction in the risk of death for patients with HER2-positive early-stage breast cancer who received a Perjeta® (pertuzumab)-based adjuvant therapy. These findings reinforce the strategic role of the Perjeta-based regimen in long-term disease management and will be presented as a late-breaking abstract at the 2025 ESMO Breast Cancer Congress.

Strategic Impact for High-Risk Patient Groups

The APHINITY study highlights even stronger benefits in a key subgroup: patients with lymph node-positive disease experienced a 21% reduction in mortality risk. This outcome strengthens the treatment’s position in clinical practice, especially for those at heightened risk of recurrence.

SHERIDAN, WYOMING – May 27, 2025 – Roche has introduced its Elecsys® PRO-C3 diagnostic test, marking a major step forward in the assessment of liver fibrosis severity, particularly in patients with metabolic dysfunction–associated steatotic liver disease (MASLD). With the ability to deliver results in just 18 minutes, the new test is poised to streamline diagnostics and enable earlier, more accurate clinical decision-making.

Strategic Response to a Global Health Burden

MASLD, affecting approximately 30% of the global population, is increasingly prevalent due to rising rates of diabetes, obesity, and other cardiometabolic risk factors. While it contributes to around one in every 25 deaths globally, liver fibrosis associated with MASLD often progresses unnoticed until late stages, escalating risks of cirrhosis, liver failure, and cancer.

SHERIDAN, WYOMING – May 27, 2025 – ANGA COM, Europe’s premier business platform for broadband, television, and online media, is set to return from June 3 to 5, 2025, in Cologne, Germany, with a bold agenda designed to shape the future of digital infrastructure and content delivery across Europe and beyond.

With more than 480 exhibitors from 35 countries and over 23,000 participants expected, ANGA COM 2025 underscores its strategic importance as a hub for the broadband and media sectors. Anchored in the economic heart of Germany’s telecommunications industry, the event offers a dynamic meeting point for network operators, technology providers, and media stakeholders to forge partnerships, showcase innovation, and debate key industry trends.

A powerhouse gathering for broadband and content leaders

SHERIDAN, WYOMING – May 27, 2025 – Hettich is redefining the digital landscape of furniture manufacturing with the introduction of intuitive assembly technologies showcased at interzum 2025. The fittings specialist is highlighting its latest advancements in user-friendly digital tools—from augmented reality and QR code guidance to a debut 3D printing portal—designed to streamline operations and enhance productivity across workshops and production facilities.

Empowering Workflows Through Digital Innovation

Hettich’s interzum 2025 presence is centered on supporting modern fabricators with practical, mobile-enabled digital services. Built on a “Bring your own device” model, these tools grant instant access to step-by-step instructions, adjustment aids, and training videos through smartphones or tablets.

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reshaping the future of space utilization with its award-winning SpinLines product family—a transformative suite of turning swivel systems designed to revolutionize how furniture and interiors function. Debuted in phases since 2019 and spotlighted at interzum 2023 and 2025, these innovative solutions enable unprecedented flexibility in residential and commercial design, offering new avenues for architects, fabricators, and furniture manufacturers.

From Turntable to Room Transformation

The journey began with a vision: rethinking how storage space is accessed and used. In collaboration with Chemnitz-based “WIRfinder” innovation network, Hettich developed the prototype ComfortSpin—a turntable that rotates cabinet or refrigerator contents to the front for easy access. The concept, rooted in translatory rotation, quickly gained traction among kitchen appliance makers and entered mass production in 2019.

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reshaping the future of workspace design with its latest innovations unveiled at interzum 2025. Under the theme “Transforming Spaces – with innovative motion,” the company presents RoomSpin and SpinLines—modular systems that bring motion, flexibility, and architectural intelligence to contract furnishing.

At its “Space and Architecture” exhibit, Hettich introduces a holistic concept for rethinking how rooms and furniture function, offering transformative solutions for compact living, open-plan environments, public spaces, and retail. The focus: adaptive interiors guided by choreographed movement.

Agile Planning for Dynamic Environments

SHERIDAN, WYOMING – May 27, 2025 – Hettich is reaffirming its role as a global innovation leader in furniture fittings at interzum 2025, unveiling a strategically aligned portfolio that meets the evolving demands of trade professionals, furniture retailers, and manufacturers. The new offerings reflect a forward-looking vision centered on user convenience, functional performance, and market adaptability—spanning living, kitchen, workspace, and outdoor applications.

Elegant Innovation: Avosys Glass and Mirror Door Hinge

Designed for premium aesthetic integration, the new Avosys hinge delivers a discreet, high-performance solution for glass and mirror cabinets. With its sleek, compact design and narrow linear mounting plate, Avosys prioritizes interior space without compromising strength.

SHERIDAN, WYOMING – May 27, 2025 – Hettich, one of the world’s leading manufacturers of furniture fittings, is poised to reshape the future of interiors with its cutting-edge innovations and sustainability-driven initiatives showcased at interzum 2025. Under the visionary theme “Transforming Spaces – with innovative motion,” the company brings forward a portfolio that highlights its commitment to customer-centric design, strategic industry collaboration, and environmentally responsible business practices.

Expanding Innovation with Strategic Product Highlights

At the forefront of Hettich’s interzum 2025 presentation are several groundbreaking product introductions designed to enhance user experience, optimize space utilization, and support evolving industry demands: